- Report
- February 2025
- 200 Pages
Global
From €4070EUR$4,490USD£3,521GBP
- Report
- August 2025
- 280 Pages
Global
From €5303EUR$5,850USD£4,588GBP
- Report
- August 2024
- 170 Pages
Global
From €4080EUR$4,500USD£3,529GBP
- Report
- November 2024
Japan, United States, ... Japan, United States, Europe
From €1360EUR$1,500USD£1,176GBP
- Report
- November 2023
- 190 Pages
Global
From €4080EUR$4,500USD£3,529GBP
- Report
- October 2023
- 146 Pages
Global
From €3762EUR$4,150USD£3,255GBP
- Report
- November 2024
Japan, United States, ... Japan, United States, Europe, Global
From €4080EUR$4,500USD£3,529GBP
- Report
- October 2024
Global
From €3173EUR$3,500USD£2,745GBP
- Report
- August 2024
Japan, United States, ... Japan, United States, Europe
From €3173EUR$3,500USD£2,745GBP
The Rabies Test market is a subset of the larger Infectious Disease Testing market. It is used to detect the presence of the rabies virus in humans and animals. Tests are typically conducted on saliva, serum, or brain tissue samples. The results of the test are used to diagnose rabies infection and to determine the need for post-exposure prophylaxis.
The Rabies Test market is driven by the increasing prevalence of rabies in both humans and animals, as well as the need for accurate and timely diagnosis. The market is also driven by the increasing demand for rapid and cost-effective testing solutions.
Companies in the Rabies Test market include Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., QIAGEN N.V., and Abbott Laboratories. Show Less Read more